These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34513602)

  • 1. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery.
    Ramos MFKP; Pereira MA; de Mello ES; Cirqueira CDS; Zilberstein B; Alves VAF; Ribeiro-Junior U; Cecconello I
    World J Clin Oncol; 2021 Aug; 12(8):688-701. PubMed ID: 34513602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
    Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Features and Prognostic Significance of Immunohistochemistry and In Situ Hybridization Based Molecular Classification in Gastric Carcinoma.
    Issin G; Sayar İ; Demir F; Bakkaloğlu İG; Gamsizkan M; Yildiz Z; Yilmaz I; Özmen SA; Çağatay DV; Zemheri IE; Demiriz M; Günal A
    J Environ Pathol Toxicol Oncol; 2023; 42(4):1-14. PubMed ID: 37522564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric cancer molecular classification and adjuvant therapy: Is there a different benefit according to the subtype?
    Ramos MFKP; Pereira MA; Amorim LC; de Mello ES; Faraj SF; Ribeiro U; Hoff PMG; Cecconello I; de Castria TB
    J Surg Oncol; 2020 Apr; 121(5):804-813. PubMed ID: 31797380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of an Easy-to-Implement, Practical Algorithm for the Identification of Molecular Subtypes of Gastric Cancer: Prognostic and Therapeutic Implications.
    Koh J; Lee KW; Nam SK; Seo AN; Kim JW; Kim JW; Park DJ; Kim HH; Kim WH; Lee HS
    Oncologist; 2019 Dec; 24(12):e1321-e1330. PubMed ID: 31371521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtraction of Epstein-Barr virus and microsatellite instability genotypes from the Lauren histotypes: Combined molecular and histologic subtyping with clinicopathological and prognostic significance validated in a cohort of 1,248 cases.
    Huang SC; Ng KF; Yeh TS; Cheng CT; Lin JS; Liu YJ; Chuang HC; Chen TC
    Int J Cancer; 2019 Dec; 145(12):3218-3230. PubMed ID: 30771224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
    J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric cancer molecular classification based on immunohistochemistry and in-situ hybridisation and mortality.
    Eskuri M; Birkman EM; Kauppila JH
    Histopathology; 2024 Aug; 85(2):327-337. PubMed ID: 38715404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognostic significance of TCGA and ACRG classification in gastric cancer among the Chinese population.
    Wang Q; Xie Q; Liu Y; Guo H; Ren Y; Li J; Zhao Q
    Mol Med Rep; 2020 Aug; 22(2):828-840. PubMed ID: 32468041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features.
    Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J
    Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite instability and Epstein-Barr virus combined with PD-L1 could serve as a potential strategy for predicting the prognosis and efficacy of postoperative chemotherapy in gastric cancer.
    Yang N; Wu Y; Jin M; Jia Z; Wang Y; Cao D; Qin L; Wang X; Zheng M; Cao X; Jiang J
    PeerJ; 2021; 9():e11481. PubMed ID: 34046266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profiles of gastric cancer molecular subtypes in remnant tumors.
    Ramos MFKP; Pereira MA; Cardili L; de Mello ES; Ribeiro U; Zilberstein B; Cecconello I
    World J Gastrointest Oncol; 2021 Apr; 13(4):265-278. PubMed ID: 33889278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Simplified Molecular Classification of Gastric Adenocarcinoma, Enhanced by Lymph Node Status: An Integrative Approach.
    Daun T; Nienhold R; Paasinen-Sohns A; Frank A; Sachs M; Zlobec I; Cathomas G
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
    Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
    Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Better Survival of MSI Subtype Is Associated With the Oxidative Stress Related Pathways in Gastric Cancer.
    Cai L; Sun Y; Wang K; Guan W; Yue J; Li J; Wang R; Wang L
    Front Oncol; 2020; 10():1269. PubMed ID: 32850385
    [No Abstract]   [Full Text] [Related]  

  • 16. Histo- and immunohistochemistry-based estimation of the TCGA and ACRG molecular subtypes for gastric carcinoma and their prognostic significance: A single-institution study.
    Yoon JY; Sy K; Brezden-Masley C; Streutker CJ
    PLoS One; 2019; 14(12):e0224812. PubMed ID: 31790410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA/ACRG classes.
    Angerilli V; Pennelli G; Galuppini F; Realdon S; Fantin A; Savarino E; Farinati F; Mastracci L; Luchini C; Fassan M
    Virchows Arch; 2022 Oct; 481(4):545-552. PubMed ID: 35925389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
    Di Pinto F; Armentano R; Arborea G; Schena N; Donghia R; Valentini AM
    Oncology; 2020; 98(8):566-574. PubMed ID: 32316005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer.
    Sun Y; Yu W; Guan W; Cai L; Qiao M; Zheng L; Jiang R; Wang R; Wang L
    Cancer Manag Res; 2019; 11():6397-6410. PubMed ID: 31372044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical Applicability.
    Pinto MP; Córdova-Delgado M; Retamal IN; Muñoz-Medel M; Bravo ML; Durán D; Villanueva F; Sanchez C; Acevedo F; Mondaca S; Koch É; Ibañez C; Galindo H; Madrid J; Nervi B; Peña J; Torres J; Owen GI; Corvalán AH; Armisén R; Garrido M
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32664343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.